Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
NASDAQ:OMCL
OMCL Stock Chart & Stats
$34.53
-$0.19(-0.44%)
At close: 4:00 PM EST
$34.53
-$0.19(-0.44%)
Day’s Range― - ―
52-Week Range$22.66 - $48.67
Previous CloseN/A
Volume97.52K
Average Volume (3M)403.84K
Market Cap
$1.53B
Enterprise Value$1.38B
Total Cash (Recent Filing)$180.05M
Total Debt (Recent Filing)$194.89M
Price to Earnings (P/E)80.7
Beta0.27
Next Earnings
Feb 05, 2026EPS Estimate
0.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.51
Shares Outstanding44,876,522
10 Day Avg. Volume404,704
30 Day Avg. Volume403,841
Financial Highlights & Ratios
PEG Ratio-1.02
Price to Book (P/B)1.65
Price to Sales (P/S)1.84
P/FCF Ratio13.55
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit2.67
Enterprise Value/Ebitda11.71
Forecast
1Y Price Target
$40.67Price Target Upside17.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.69
Revenue Forecast (FY)$1.18B
Bulls Say, Bears Say
Bulls Say
Product TractionOMCL reported an upside 3Q print and 4Q guide providing further evidence that the XTExtend and Amplify product offerings are gaining increasing traction and beginning to enhance gross margins.
Revenue GuidanceFull-year mid-point guidance for revenue, non-GAAP EBITDA and non-GAAP EPS were lifted to reflect both the better 3Q and 4Q outlook.
Services RevenueFY25 Services revenue guidance was lifted on the strength of technical services and specialty pharmacy services more than offsetting some retail pharmacy headwinds impacting Enliven.
Bears Say
Gross Profit MarginNon-GAAP gross profit margin was down 30 bps y/y and 50 bps q/q reflecting the increased net tariff impact.
Pharmacy IT BudgetsPharmacy IT budget growth expectations fell for the second consecutive quarter.
Tariff ImpactOMCL also has meaningful exposure to any incremental China tariffs, another consideration given last week’s news.
Omnicell News
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $22.66 and its highest was $48.67 in the past 12 months.
What is Omnicell’s market cap?
Omnicell’s market cap is $1.53B.
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Feb 05, 2026 which is in 76 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Oct 30, 2025. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.362 by $0.148.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is 0.49.
How many shares outstanding does Omnicell have?
Omnicell has 44,876,522 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.51 in its last earnings report, beating expectations of $0.362. Following the earnings report the stock price went up 13.561%.
Which hedge fund is a major shareholder of Omnicell?
Currently, no hedge funds are holding shares in OMCL
Omnicell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$40.67 (17.78% Upside)
$40.67 (17.78% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 260.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-25.25%
12-Months-Change
Fundamentals
Return on Equity
1.62%
Trailing 12-Months
Asset Growth
-15.41%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. is a healthcare technology company that specializes in medication management solutions and supply chain automation. Founded in 1992 and headquartered in Mountain View, California, Omnicell operates primarily in the healthcare sector, providing innovative products and services designed to improve patient safety, enhance operational efficiency, and streamline pharmacy and medication management processes. Its core offerings include automated medication dispensing systems, pharmacy management software, and inventory management solutions, which are utilized by hospitals, long-term care facilities, and outpatient pharmacies.
OMCL Company Deck
OMCL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and successful execution against guidance, particularly in point-of-care solutions and the OmniSphere platform. However, there were notable challenges including a decrease in both GAAP and Non-GAAP EPS, tariff impacts on profitability, and slower growth in certain service revenues. Despite these challenges, the company's strategic initiatives and product adoption indicate positive momentum.View all OMCL earnings summariesOMCL Stock 12 Month Forecast
Average Price Target
$40.67
▲(17.78% Upside)
Technical Analysis
Ownership Overview
2.94% Insiders
29.48% Mutual Funds
0.63% Other Institutional Investors
34.85% Public Companies and
Individual Investors